Induztr
Résumé technique Visionneuse de documents Modèles associés

Cancer Immunotherapy: Real-Time Cell Analysis Assays with xCELLigence

Sommaire

  1. p. 2
    Document contents listing with page references
  2. Overview p. 3
    Introduction to oncolytic virus immunotherapy assays
  3. Overview pp. 4-5
    Background on cancer immunotherapy and assay needs
  4. Overview pp. 6-8
    Principle of real-time cellular impedance measurement
  5. Spec pp. 9-10
    Overview and specifications of RTCA instrument models
  6. Procedure pp. 11-14
    Antibody-dependent cell-mediated cytolysis assay protocols and data
  7. Procedure pp. 15-18
    Bispecific T cell engager killing assays and results
  8. Procedure pp. 19-22
    PD-1 checkpoint inhibitor target cell killing assays
  9. Procedure pp. 23-25
    Combination immunotherapy treatment assays
  10. Procedure pp. 26-31
    CAR T and genetically engineered T cell cytotoxicity assays
  11. Procedure pp. 32-34
    Macrophage-mediated phagocytosis assays on adherent targets
  12. Procedure pp. 35-39
    Natural killer cell-mediated cytolysis assays and cell lines
  13. Procedure pp. 40-43
    Oncolytic virus killing assays and supporting information
  14. Procedure pp. 44-47
    T cell-mediated cytolysis assays and adherent target cells
  15. Procedure pp. 48-51
    Liquid tumor killing assays and B cell immobilization
  16. p. 52
    Disclaimer and information change notice
  17. p. 10 table, 15 rows
  18. p. 3 table, 6 rows

Table 1. Overview of Agilent xCELLigence RTCA instruments.

Dual Purpose (DP)Single Plate (SP)Multiple Plates (MP)High Throughput (HT)
eSight
Applicable to both liquid and solid tumor target cells
Cell-mediated cytotoxicity
ADCC
Checkpoint inhibitors
Combination therapies
Antibody-drug conjugates
Immune cell activation
Cell invasion and migration
Live cell imaging
Specifications
Format3 × 16 wells1 × 96 wells6 × 96 wells1 × 384 wells
3 × 96 wells impedance5 × 96 wells imaging
Maximum throughput48 wells96 wells576 wellsUp to 4 × 382 wells (1,536 wells total)
288 wells impedanceUp to 480 wells total for imaging

Table

РазделСтраница
Oncolytic viruses40
Selected publications41
T Cell-mediated cytolysis44
Selected publications45
Liquid tumor killing assays48
Selected publications50

Engineering Facts

13 facts · every claim linked to a page
Selection

Choose the instrument model by plate format and throughput, since all models measure impedance identically but differ in plate configuration and throughput.

Determines which RTCA model fits the required plate count and assay throughput before purchase.

Source
“they differ from one another in plate configuration and throughput”
Selection

The DP model adds quantitative invasion/migration monitoring via a specialized electronic Boyden chamber plate, so select DP if migration assays are needed.

Adds a required capability for labs running invasion/migration studies.

Source
“The DP model has the additional capability to quantitatively monitor cell invasion/migration by using a specialized plate that functions as an electronic Boyden chamber.”
Selection

The eSight model adds three-color plus brightfield imaging, so choose it when live cell imaging is required alongside impedance.

Imaging capability is a hard selection criterion if microscopy data is needed.

Source
“The eSight incorporates imaging in three colors, plus brightfield.”
Installation

Instruments must sit inside a standard tissue culture incubator or hypoxia chamber (except HT), with control units outside, so plan incubator space and cable routing.

Drives incubator space, cable pass-through, and external control unit placement during installation.

Source
“xCELLigence instruments are housed inside standard tissue culture incubators or hypoxia chambers, except for the HT model”
Installation

The HT model is the exception and can run standalone, so it does not need to be placed inside an incubator.

Changes site requirements and environmental control planning for high-throughput setups.

Source
“though the HT model can be run as a standalone instrument”
Operation

Only adherent target cells generate signal; nonadherent effector cells do not change impedance, so the assay requires adherent targets.

Defines the biological preconditions for a valid impedance-based killing assay.

Source
“nonadherent effector cells (that is, immune cells) in suspension do not cause signal changes due to lack of adherence to the gold biosensors”
Operation

The workflow is simply plate targets, add effectors, and start reading, enabling real-time killing curves over seconds to days.

Confirms minimal hands-on steps and continuous kinetic readout for assay design.

Source
“Plate target cells, add effector cells, and start reading.”
Performance

A full 96-well plate reads in 15 seconds and up to six plates run independently without scheduling conflicts.

Sets throughput and scheduling expectations for multi-plate experiments.

Source
“Read an entire 96-well plate in 15 seconds and run up to six plates independently, with no scheduling conflicts.”
Performance

Biosensors cover about 75% of the well bottom, enabling simultaneous monitoring of large cell populations.

Explains signal sensitivity and the large monitored cell population per well.

Source
“The gold biosensors in each well of Agilent electronic microplates (E‑Plates) cover ~75% of the bottom surface area.”
Operation

The central well region supports microscopic imaging even though cells grow on the gold biosensor surfaces.

Allows combined impedance and microscopy workflows without redesigning plates.

Source
“the region in the middle of the well facilitates microscopic imaging”
Operation

Percent cytolysis is computed from the ratio of Cell Index without effector minus with effector to Cell Index without effector, times 100.

Defines the calculation needed to convert raw impedance into reported killing data.

Source
“%Cytolysis = (Cell Indexno effector – Cell Indexeffector) Cell Indexno effector × 100”
Performance

Impedance monitoring is sensitive enough to detect target cell killing even at low effector-to-target ratios.

Supports use of limited effector cell numbers in assay design.

Source
“Real‑time impedance monitoring by the xCELLigence system is sensitive enough to detect target cell killing even at low E:T ratios.”
Operation

For liquid tumors, precoating E-Plate wells with anti-CD40 antibody immobilizes B cells so they can proliferate and be detected by the sensors.

Required preparation step for adapting the impedance assay to nonadherent liquid tumor cells.

Source
“Precoating the wells of Agilent E-Plates with B cell-specific antibody (anti-CD40) enables B cells to proliferate on, and be detected by, the sensors.”